MedTrace Logo

Safety and Feasibility Study of Administration of Mesenchymal Stemcells for Treatment of Emphysema

NCT01306513 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2012-11-19

No results posted yet for this study

Summary

The purpose of this study is to show safety and feasibility to administer patients own mesenchymal stem cells to show signs of repair of emphysematous lung tissue

Conditions

  • Emphysema

Interventions

BIOLOGICAL

autologous bone marrow derived mesenchymal stromal cells

Intravenous administration of autologous bone marrow-derived mesenchymal stromal cells.

Sponsors & Collaborators

  • Leiden University Medical Center

    lead OTHER

Principal Investigators

  • Jan Stolk, MD, PhD · Leiden University Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2012-06-30
Completion
2012-11-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01306513 on ClinicalTrials.gov